1. Home
  2. VTSI vs TLSA Comparison

VTSI vs TLSA Comparison

Compare VTSI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$3.76

Market Cap

51.1M

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.24

Market Cap

155.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
TLSA
Founded
1993
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.1M
155.2M
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
VTSI
TLSA
Price
$3.76
$1.24
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
46.1K
132.9K
Earning Date
03-26-2026
05-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$185,971.00
N/A
Revenue This Year
$28.39
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$186.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$0.73
52 Week High
$7.47
$2.60

Technical Indicators

Market Signals
Indicator
VTSI
TLSA
Relative Strength Index (RSI) 34.11 42.22
Support Level N/A N/A
Resistance Level $5.15 $1.51
Average True Range (ATR) 0.23 0.11
MACD -0.05 -0.00
Stochastic Oscillator 17.00 25.00

Price Performance

Historical Comparison
VTSI
TLSA

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS. Its flagship immunotherapeutic candidate, Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody, is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's and other CNS indications.

Share on Social Networks: